Mitigation of SARS-CoV-2 by Using Transition Metal Nanozeolites and Quaternary Ammonium Compounds as Antiviral Agents in Suspensions and Soft Fabric Materials.


Journal

International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847

Informations de publication

Date de publication:
2023
Historique:
received: 14 01 2023
accepted: 05 04 2023
medline: 12 5 2023
pubmed: 10 5 2023
entrez: 10 5 2023
Statut: epublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the need for novel, affordable, and efficient reagents to help reduce viral transmission, especially in high-risk environments including medical treatment facilities, close quarters, and austere settings. We examined transition-metal nanozeolite suspensions and quaternary ammonium compounds as an antiviral surface coating for various textile materials. Zeolites are crystalline porous aluminosilicate materials, with the ability of ion-exchanging different cations. Nanozeolites (30 nm) were synthesized and then ion-exchanged with silver, zinc and copper ions. Benzalkonium nitrate (BZN) was examined as the quaternary ammonium ion (quat). Suspensions of these materials were tested for antiviral activity towards SARS-CoV-2 using plaque assay and immunostaining. Suspensions of the nanozeolite and quat were deposited on polyester and cotton fabrics and the ability of these textiles towards neutralizing SARS-CoV-2 was examined. We hypothesized that transition metal ion containing zeolites, particularly silver and zinc (AM30) and silver and copper (AV30), would be effective in reducing the infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Additionally, AM30 and AV30 antiviral potency was tested when combined with a quaternary ammonium carrier, BZN. Our results indicate that exposure of SARS-CoV-2 to AM30 and/or AV30 suspensions reduced viral loads with time and exhibited dose-dependence. Antiviral activities of the combination of zeolite and BZN compositions were significantly enhanced. When used in textiles, AM30 and AV30-coated cotton and polyester fabrics alone or in combination with BZN exhibited significant antiviral properties, which were maintained even after various stress tests, including washes, SARS-CoV-2-repeated exposures, or treatments with soil-like materials. This study shows the efficacy of transition metal nanozeolite formulations as novel antiviral agents and establishes that nanozeolite with silver and zinc ions (AM30) and nanozeolite with silver and copper ions (AV30) when combined with benzalkonium nitrate (BZN) quickly and continuously inactivate SARS-CoV-2 in suspension and on fabric materials.

Identifiants

pubmed: 37163142
doi: 10.2147/IJN.S396669
pii: 396669
pmc: PMC10164392
doi:

Substances chimiques

Antiviral Agents 0
Silver 3M4G523W1G
Copper 789U1901C5
Quaternary Ammonium Compounds 0
Benzalkonium Compounds 0
Suspensions 0
Zeolites 1318-02-1
Nitrates 0
Zinc J41CSQ7QDS
Polyesters 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2307-2324

Informations de copyright

© 2023 Guerrero-Arguero et al.

Déclaration de conflit d'intérêts

ZeoVation is a startup company that grew out of the research at The Ohio State University (OSU), and the authors from OSU are involved with the company. Prabir K. Dutta and Sweta Shrestha are financially supported by ZeoVation, Inc. Prabir K. Dutta, W. James Waldman and D. Knight have financial investments in ZeoVation. The authors report no other conflicts of interest in this work.

Références

Int J Nanomedicine. 2011;6:1833-52
pubmed: 21931480
J Appl Microbiol. 2018 May;124(5):1032-1046
pubmed: 29280540
J Hazard Mater. 2016 Jul 15;312:1-7
pubmed: 27015373
Viruses. 2012 Nov 12;4(11):3044-68
pubmed: 23202515
Perit Dial Int. 2003 Jul-Aug;23(4):368-74
pubmed: 12968845
Int J Environ Res Public Health. 2016 Apr 19;13(4):430
pubmed: 27104546
Molecules. 2011 Oct 24;16(10):8894-918
pubmed: 22024958
Int J Environ Res Public Health. 2021 Oct 20;18(21):
pubmed: 34769538
iScience. 2022 May 30;25(7):104475
pubmed: 35789852
Vet Rec. 1971 Dec 4;89(23):609-10
pubmed: 5167714
Nature. 2020 Dec;588(7838):498-502
pubmed: 32805734
Nanomaterials (Basel). 2021 May 17;11(5):
pubmed: 34067553
Pathog Glob Health. 2020 Oct;114(7):349-359
pubmed: 32877308
Appl Environ Microbiol. 2015 Jan;81(2):464-9
pubmed: 25362069
ACS Nano. 2020 Oct 27;14(10):12341-12369
pubmed: 33034443
ACS Appl Mater Interfaces. 2021 Feb 10;13(5):5919-5928
pubmed: 33480246
Appl Environ Microbiol. 2015 Feb;81(3):1085-91
pubmed: 25452290
Curr Opin Biomed Eng. 2022 Mar;21:100363
pubmed: 34869963
ACS Infect Dis. 2020 Jul 10;6(7):1553-1557
pubmed: 32412231
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Appl Environ Microbiol. 2021 Sep 10;87(19):e0109821
pubmed: 34288707
Antimicrob Resist Infect Control. 2021 Sep 10;10(1):133
pubmed: 34507617
Am J Infect Control. 2013 Oct;41(10):908-11
pubmed: 23623007
Biochem Biophys Res Commun. 2020 Nov 26;533(1):195-200
pubmed: 32958250
Jpn J Microbiol. 1974 Mar;18(2):107-12
pubmed: 4372429
J Nanobiotechnology. 2005 Jun 29;3:6
pubmed: 15987516
Arch Toxicol. 2012 Jul;86(7):1123-36
pubmed: 22407301
Appl Environ Microbiol. 1993 Dec;59(12):4374-6
pubmed: 8285724
Regul Toxicol Pharmacol. 2013 Dec;67(3):456-67
pubmed: 24080225
Crit Rev Microbiol. 2016;42(1):46-56
pubmed: 24754250
Int J Biol Macromol. 2014 Apr;65:509-15
pubmed: 24530328
BMC Microbiol. 2016 Apr 01;16 Suppl 1:56
pubmed: 27036553
Appl Environ Microbiol. 2012 Apr;78(7):2456-8
pubmed: 22287007
Curr Opin Colloid Interface Sci. 2021 Oct;55:101479
pubmed: 34149296
ACS Nano. 2020 May 26;14(5):6348-6356
pubmed: 32368894
J Antimicrob Chemother. 2008 Apr;61(4):869-76
pubmed: 18305203
J Appl Microbiol. 2005;99(4):703-15
pubmed: 16162221
Emerg Infect Dis. 2021 Apr;27(4):1229-1231
pubmed: 33755002
J Hosp Infect. 2020 Dec;106(4):678-697
pubmed: 32956786
Int J Mol Sci. 2019 Feb 17;20(4):
pubmed: 30781560
World J Microbiol Biotechnol. 2021 Jan 11;37(2):22
pubmed: 33428020
Environ Sci Technol. 2011 Feb 15;45(4):1177-83
pubmed: 21218770
J Hyg (Lond). 1986 Aug;97(1):139-61
pubmed: 3016081
Biomater Sci. 2022 Aug 9;10(16):4392-4423
pubmed: 35796210
J Nanobiotechnology. 2010 Jan 20;8:1
pubmed: 20145735
Environ Sci Process Impacts. 2020 Jun 24;22(6):1368-1381
pubmed: 32406464
J Nanobiotechnology. 2022 Oct 8;20(1):440
pubmed: 36209089
Materials (Basel). 2020 Apr 01;13(7):
pubmed: 32244687
J Mater Chem B. 2021 Jun 16;9(23):4620-4642
pubmed: 34027540
Nature. 1974 Apr 12;248(449):588-90
pubmed: 4363085
J Hosp Infect. 2021 Feb;108:142-145
pubmed: 33259880
Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:902-912
pubmed: 30184820
J Drug Deliv Sci Technol. 2022 Jan;67:102967
pubmed: 34777586
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052
Pharm Res. 2020 May 25;37(6):104
pubmed: 32451736

Auteurs

Israel Guerrero-Arguero (I)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Siddiqur Rahman Khan (SR)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Brandon M Henry (BM)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Andreu Garcia-Vilanova (A)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Kevin Chiem (K)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Chengjin Ye (C)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Sweta Shrestha (S)

ZeoVation Inc., Columbus, OH, USA.

Deborah Knight (D)

Department of Pathology, The Ohio State University, Columbus, OH, USA.

Mark Cristner (M)

Chief Scientist's Office of Science and Technology, 59th Medical Wing, Joint Base San Antonio-Lackland, San Antonio, TX, USA.

Shauna Hill (S)

Chief Scientist's Office of Science and Technology, 59th Medical Wing, Joint Base San Antonio-Lackland, San Antonio, TX, USA.

W James Waldman (WJ)

Department of Pathology, The Ohio State University, Columbus, OH, USA.

Prabir K Dutta (PK)

ZeoVation Inc., Columbus, OH, USA.
Department of Chemistry, The Ohio State University, Columbus, OH, USA.

Jordi B Torrelles (JB)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Luis Martinez-Sobrido (L)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.

Amber M Nagy (AM)

Disease Intervention & Prevention and Population Health Programs, Texas Biomedical Research Institute, San Antonio, TX, USA.
Chief Scientist's Office of Science and Technology, 59th Medical Wing, Joint Base San Antonio-Lackland, San Antonio, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH